On Monday, RBC Capital maintained an Outperform rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT), while increasing the price... Read this story
On Monday, RBC Capital maintained an Outperform rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT), while increasing the price... Read this story
More from Investing.com UK | Stock Technical analysis Nasdaq